Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 525

    3.

    Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice.

    Lewis P, Stefanovic N, Pete J, Calkin AC, Giunti S, Thallas-Bonke V, Jandeleit-Dahm KA, Allen TJ, Kola I, Cooper ME, de Haan JB.

    Circulation. 2007 Apr 24;115(16):2178-87. Epub 2007 Apr 9.PMID: 17420349 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A 1,3-diacylglycerol-rich oil induces less atherosclerosis and lowers plasma cholesterol in diabetic apoE-deficient mice.

    Fujii A, Allen TJ, Nestel PJ.

    Atherosclerosis. 2007 Jul;193(1):55-61. Epub 2006 Sep 22.PMID: 16996521 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.

    Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B.

    Circulation. 2008 Jan 22;117(3):421-8. Epub 2007 Dec 24.PMID: 18158360 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats.

    Maritim AC, Sanders RA, Watkins JB 3rd.

    J Nutr Biochem. 2003 May;14(5):288-94.PMID: 12832033 [PubMed - indexed for MEDLINE]Related articles

    7.

    Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocin-diabetes.

    Koçak G, Aktan F, Canbolat O, Ozoğul C, Elbeğ S, Yildizoglu-Ari N, Karasu C; ADIC Study Group--Antioxidants in Diabetes-Induced Complications.

    Diabetes Nutr Metab. 2000 Dec;13(6):308-18.PMID: 11232755 [PubMed - indexed for MEDLINE]Related articles

    8.

    Swimming reduces the severity of atherosclerosis in apolipoprotein E deficient mice by antioxidant effects.

    Okabe TA, Shimada K, Hattori M, Murayama T, Yokode M, Kita T, Kishimoto C.

    Cardiovasc Res. 2007 Jun 1;74(3):537-45. Epub 2007 Feb 21.PMID: 17374527 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.

    Chew P, Yuen DY, Koh P, Stefanovic N, Febbraio MA, Kola I, Cooper ME, de Haan JB.

    Arterioscler Thromb Vasc Biol. 2009 Jun;29(6):823-30. Epub 2009 Mar 26.PMID: 19325139 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effects of high-fat, low-cholesterol diets on hepatic lipid peroxidation and antioxidants in apolipoprotein E-deficient mice.

    Ferré N, Camps J, Paul A, Cabré M, Calleja L, Osada J, Joven J.

    Mol Cell Biochem. 2001 Feb;218(1-2):165-9.PMID: 11330832 [PubMed - indexed for MEDLINE]Related articles

    11.

    The thromboxane A2 receptor antagonist S18886 prevents enhanced atherogenesis caused by diabetes mellitus.

    Zuccollo A, Shi C, Mastroianni R, Maitland-Toolan KA, Weisbrod RM, Zang M, Xu S, Jiang B, Oliver-Krasinski JM, Cayatte AJ, Corda S, Lavielle G, Verbeuren TJ, Cohen RA.

    Circulation. 2005 Nov 8;112(19):3001-8. Epub 2005 Oct 31.PMID: 16260636 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Chronic hyperbaric oxygen treatment elicits an anti-oxidant response and attenuates atherosclerosis in apoE knockout mice.

    Kudchodkar BJ, Pierce A, Dory L.

    Atherosclerosis. 2007 Jul;193(1):28-35. Epub 2006 Sep 14.PMID: 16973170 [PubMed - indexed for MEDLINE]Related articles

    13.

    Palm tocotrienols protect ApoE +/- mice from diet-induced atheroma formation.

    Black TM, Wang P, Maeda N, Coleman RA.

    J Nutr. 2000 Oct;130(10):2420-6.PMID: 11015467 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Decreased lipoprotein clearance is responsible for increased cholesterol in LDL receptor knockout mice with streptozotocin-induced diabetes.

    Goldberg IJ, Hu Y, Noh HL, Wei J, Huggins LA, Rackmill MG, Hamai H, Reid BN, Blaner WS, Huang LS.

    Diabetes. 2008 Jun;57(6):1674-82. Epub 2008 Mar 17.PMID: 18346984 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Farnesyltransferase inhibitor, manumycin a, prevents atherosclerosis development and reduces oxidative stress in apolipoprotein E-deficient mice.

    Sugita M, Sugita H, Kaneki M.

    Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1390-5. Epub 2007 Mar 15.PMID: 17363690 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Effects of streptozotocin-induced diabetes in apolipoprotein AI deficient mice.

    Goldberg IJ, Isaacs A, Sehayek E, Breslow JL, Huang LS.

    Atherosclerosis. 2004 Jan;172(1):47-53.PMID: 14709356 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mechanisms of antioxidant and pro-oxidant effects of alpha-lipoic acid in the diabetic and nondiabetic kidney.

    Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C.

    Kidney Int. 2005 Apr;67(4):1371-80.PMID: 15780089 [PubMed - indexed for MEDLINE]Related articles

    19.

    Metabolic effects of gamma-linolenic acid-alpha-lipoic acid conjugate in streptozotocin diabetic rats.

    Khamaisi M, Rudich A, Beeri I, Pessler D, Friger M, Gavrilov V, Tritschler H, Bashan N.

    Antioxid Redox Signal. 1999 Winter;1(4):523-35.PMID: 11233149 [PubMed - indexed for MEDLINE]Related articles

    20.

    IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice.

    Sukhanov S, Higashi Y, Shai SY, Vaughn C, Mohler J, Li Y, Song YH, Titterington J, Delafontaine P.

    Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2684-90. Epub 2007 Oct 4.PMID: 17916769 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data